Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5APG6

Entry ID Method Resolution Chain Position Source
AF-Q5APG6-F1 Predicted AlphaFoldDB

No variants for Q5APG6

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5APG6

No associated diseases with Q5APG6

No regional properties for Q5APG6

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q5APG6

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleolar ring Ring-like structures located at the nucleolar periphery where several nuclear factors are reversibly aggregated and sequestered during acute heat stress.
post-mRNA release spliceosomal complex A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and three snRNPs, including U5.
Prp19 complex A protein complex consisting of Prp19 and associated proteins that is involved in the transition from the precatalytic spliceosome to the activated form that catalyzes step 1 of splicing, and which remains associated with the spliceosome through the second catalytic step. It is widely conserved, found in both yeast and mammals, though the exact composition varies. In S. cerevisiae, it contains Prp19p, Ntc20p, Snt309p, Isy1p, Syf2p, Cwc2p, Prp46p, Clf1p, Cef1p, and Syf1p.
spliceosomal complex Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA.

1 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

2 GO annotations of biological process

Name Definition
mRNA cis splicing, via spliceosome The joining together, after removal of an intervening sequence composed of one or more introns, of two segments of the same RNA molecule via spliceosomal catalysis to produce an mRNA composed only of exon sequences that all came from the same primary transcript.
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAPPLYVKGG VWTNVEDEIL KAAIQKYGIY QWERISSLLP KKSAKQVKAR WVEYLSPLLN
70 80 90 100 110 120
KTDWTKEEDE KLLNLHKIFP NQWRSISNIL NRTAVQCVER YQKLIDEAAG IKPGDDEENL
130 140 150 160 170 180
GLSGPGIETL PAVGASSGLA VGEMNLNPES KPARPDDEDL PDDEREMLAE AKARLGNIQG
190 200 210 220 230 240
KKAKRKARER MLEESKRIAL LQKRRELKSA GINVKLTTRN KKKRKEFDYN ADIPHEIIPQ
250 260 270 280 290 300
AGPYDTAEEL KQNDFEKQQF GQQVSTKGIS MKDIDDRIAK EESRRKKEIE KKKLERKREF
310 320 330 340 350 360
NAAASLISEH EDSKRRKLNL PEPGTHNFEK TKSDVLTLTN QANNKLSEKE IARNQNKKRA
370 380 390 400 410 420
AVAQLIKATF ERLPPPKHET GEILPFVSTN ILEFRNDVNA NDISDIAGAK LPDETATNVS
430 440 450 460 470 480
TLISRVVQRE LPIPHPNNLR DLSTVKFDTL VDKLIAEECH RLIRSDYKQY HDTTINGVST
490 500 510 520 530 540
DKYDRDLLEK INQDIDKEFA QMDVSTVHSF EDYVLPKNFK VAESIIENLH TFHNENEKLT
550 560 570 580 590 600
NKILESTNYE DQRDQKLQQL THLWRELSDV NLSYSIEKKL FELESSAIDK ELLRLRSEID
KLNKKIETLR